The pursuit of optimal semaglutide dosing in type 2 diabetes continues. Sherrill CH, Hwang AY. Lancet 2023 Jun 23:S0140-6736(23)01233-3. doi: 10.1016/S0140-6736(23)01233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sherrill CH, Hwang AY. The pursuit of optimal semaglutide dosing in type 2 diabetes continues. Lancet 2023 Jun 23:S0140-6736(23)01233-3. doi: 10.1016/S0140-6736(23)01233.
PMID: 37385277